VCR ventracor limited

dt and btt trials running together, page-7

  1. Vyking
    395 Posts.
    clock Created with Sketch.
    29/05/07
    22:12
    Post #: 2492387
    From press release on April 5, 2007

    “The VentrAssist US BTT trial will involve up to 140 patients at leading heart transplant hospitals in America.
    ..............................
    “The target clinical performance of the VentrAssist in the BTT trial is for 75 percent of the patients to either have a heart transplant or still be listed for heart transplant at 180 days after implant of the VentrAssist.
    VCR Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS AnteoTech and Black Diamond Structures to Progress Advanced Battery Product in the USA
right-arrow Created with Sketch.
NEWS World’s largest pollucite-hosted caesium pegmatite resource defined
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.